Study characteristics | N (%) | References |
---|---|---|
Country | ||
Australia | 1 (3%) | [47] |
Canada | 3 (9%) | |
France | 12 (34%) | |
Italy | 1 (3%) | [48] |
Netherlands | 3 (9%) | |
USA | 15 (42%) | |
Publication year | ||
2016–2021 | 6 (17%) | |
2011–2015 | 11 (32%) | |
2006–2010 | 5 (14%) | |
2001–2005 | 8 (23%) | |
< 2001 | 5 (14%) | |
Study design | ||
Randomized controlled trial | 6 (17%) | |
Controlled before after study | 4 (11%) | |
Non-controlled before-after study | 8 (23%) | |
Prospective cohort study | 1 (3%) | [70] |
Mixed-methods | 1 (3%) | [36] |
Cross-sectional | 3 (9%) | |
Case study | 12 (34%) | |
Type of guidelines‡ | ||
Screening | 7 (20%) | |
Diagnosis | 5 (14%) | |
Treatment | 9 (26%) | |
Diagnosis and treatment | 11 (31%) | |
Surveillance/follow-up/rehabilitation | 3 (9%) | |
Type of intervention | ||
Computerized decision support systems | 12 (34%) | |
Educational interventions | 7 (20%) | |
Multifaceted | 9 (25%) | |
Audit and feedback | 2 (6%) | |
Clinical pathways | 1 (3%) | [56] |
Integrated knowledge translation | 1 (3%) | [61] |
Medical critiquing system | 1 (3%) | [52] |
Medical home program | 1 (3%) | [70] |
Provider reminders | 1 (3%) | [45] |
Outcomes assessed | ||
Intervention adoption/fidelity | 2 (6%) | |
Impact on providers attitudes/knowledge/self-efficacy | 4 (12%) | |
Impact on compliance with CPG recommendations | 30 (85%) | [36,37,38,39,40,41,42,43, 45,46,47,48,49,50,51, 53,54,55,56, 58,59,60, 62, 63, 65,66,67,68,69,70] |
Impact on patient health related outcomes | 0 (0%) | – |
Costs of implementing the interventions | 1 (3%) | [44] |
Risk of bias | ||
Low | 5 (14%) | |
Moderate | 10 (29%) | |
High | 5 (14%) | |
Unclear | 4 (11%) | |
Not assessed (case studies) a | 11 (31%) |